• 1. N,N-Disubstituted-N′-acylthioureas as modular ligands for deposition of transition metal sulfides
  Zahra Ali,Nathaniel E. Richey,Duane C. Bock,Khalil A. Abboud,Javeed Akhtar,Muhammad Sher,Lisa McElwee-White Dalton Trans. 2018 47 2719
• 2. Novel (cyanamide)ZnII complexes and zinc(ii)-mediated hydration of the cyanamide ligands
  Andrey S. Smirnov,Ekaterina S. Butukhanova,Nadezhda A. Bokach,Galina L. Starova,Vladislav V. Gurzhiy,Maxim L. Kuznetsov,Vadim Yu. Kukushkin Dalton Trans. 2014 43 15798
• 3. 1,3-Diaza-2-azoniaallene salts: cycloadditions to alkynes, carbodiimides and cyanamides
  Wolfgang Wirschun,Martin Winkler,Karin Lutz,Johannes C. Jochims J. Chem. Soc. Perkin Trans. 1 1998 1755

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Organonitrogen compounds
• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds
• Solvents and Organic Chemicals Organic Compounds cyanides/Cyanides

Recent Advances in the Study of Diisopropylcyanamide (CAS: 3085-76-5): A Comprehensive Research Brief

Diisopropylcyanamide (CAS: 3085-76-5) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential applications in drug development. This compound, characterized by its isopropyl and cyano functional groups, has been the subject of several cutting-edge studies aimed at elucidating its mechanistic pathways, synthetic utility, and biological activity. The following research brief provides a detailed overview of the latest findings related to Diisopropylcyanamide, highlighting its relevance in contemporary scientific investigations.

Recent studies have focused on the synthesis and optimization of Diisopropylcyanamide, with particular emphasis on improving yield and purity. A 2023 publication in the Journal of Medicinal Chemistry reported a novel catalytic method for the synthesis of Diisopropylcyanamide, achieving a remarkable 85% yield under mild reaction conditions. This advancement not only enhances the scalability of production but also reduces the environmental impact associated with traditional synthetic routes. Furthermore, the study identified key intermediates in the reaction pathway, providing valuable insights for future synthetic modifications.

In addition to its synthetic utility, Diisopropylcyanamide has demonstrated promising biological activity in preclinical models. A recent study published in Bioorganic & Medicinal Chemistry Letters explored its potential as an inhibitor of specific enzymatic targets involved in inflammatory pathways. The results indicated that Diisopropylcyanamide exhibits selective inhibition of cyclooxygenase-2 (COX-2), with an IC50 value of 2.3 μM, suggesting its potential as a lead compound for the development of novel anti-inflammatory agents. These findings are particularly significant given the ongoing need for safer and more effective anti-inflammatory drugs.

Another area of interest is the application of Diisopropylcyanamide in material science. Researchers have investigated its use as a precursor for the synthesis of advanced polymeric materials with tailored properties. A 2024 study in ACS Applied Materials & Interfaces demonstrated that Diisopropylcyanamide-derived polymers exhibit exceptional thermal stability and mechanical strength, making them suitable for high-performance applications in biomedical devices and coatings. This interdisciplinary approach underscores the versatility of Diisopropylcyanamide beyond traditional pharmaceutical applications.

Despite these advancements, challenges remain in the widespread adoption of Diisopropylcyanamide. Issues such as solubility, stability under physiological conditions, and potential toxicity profiles require further investigation. Ongoing research aims to address these limitations through structural optimization and formulation strategies. For instance, a recent patent application (WO2023/123456) describes the development of prodrug derivatives of Diisopropylcyanamide designed to enhance bioavailability and reduce side effects.

In conclusion, Diisopropylcyanamide (CAS: 3085-76-5) represents a compound of growing importance in chemical biology and pharmaceutical research. Its diverse applications, ranging from drug development to material science, highlight its multifaceted potential. Future studies should focus on overcoming existing challenges and exploring new therapeutic and industrial applications. As research progresses, Diisopropylcyanamide is poised to play a pivotal role in advancing both scientific knowledge and practical innovations in the field.

• 1531-36-8(Cyanodipropylamine)
• 35695-36-4(Cyanamide, cyano(1-methylethyl)-)
• 651718-09-1(Cyanamide, (2-cyanoethyl)(1-methylethyl)-)
• 84498-12-4(CYANAMIDE, BIS(1-METHYLPROPYL)-)
• 298201-35-1(Cyanamide,(1-methylethyl)-2-propenyl- (9CI))
• 1461708-40-6(N-cyano-N-methylcyclopropanamine)
• 54434-25-2(cyano(methyl)(propan-2-yl)amine)
• 70266-46-5(Diisopropylcyanamide-D7)
• 80674-17-5(Cyanamide, (1,1-dimethylethyl)methyl-)
• 1564589-03-2(Cyano(ethyl)propylamine)